| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | SUMO ligase activity | 1.25e-05 | 20 | 147 | 4 | GO:0061665 | |
| GeneOntologyMolecularFunction | CTP synthase activity | 5.38e-05 | 2 | 147 | 2 | GO:0003883 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 1.38e-04 | 36 | 147 | 4 | GO:0019789 | |
| GeneOntologyMolecularFunction | hemi-methylated DNA-binding | 1.61e-04 | 3 | 147 | 2 | GO:0044729 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase activity | RGPD4 UBR2 UBE4B RGPD1 TRIM71 FBXO30 PIAS4 UBR5 RGPD3 TRIM55 UHRF1 | 1.80e-04 | 398 | 147 | 11 | GO:0061659 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 2.41e-04 | 118 | 147 | 6 | GO:0003774 | |
| GeneOntologyMolecularFunction | H3K9me3 modified histone binding | 3.20e-04 | 4 | 147 | 2 | GO:0062072 | |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 2.83e-05 | 9 | 146 | 3 | GO:0033133 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 4.02e-05 | 10 | 146 | 3 | GO:1903301 | |
| GeneOntologyBiologicalProcess | 'de novo' CTP biosynthetic process | 4.98e-05 | 2 | 146 | 2 | GO:0044210 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 1.90e-05 | 8 | 148 | 3 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 4.02e-05 | 10 | 148 | 3 | GO:0044614 | |
| GeneOntologyCellularComponent | annulate lamellae | 1.20e-04 | 14 | 148 | 3 | GO:0005642 | |
| GeneOntologyCellularComponent | cytoophidium | 1.49e-04 | 3 | 148 | 2 | GO:0097268 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 2.62e-04 | 18 | 148 | 3 | GO:0044615 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 3.63e-04 | 20 | 148 | 3 | GO:0042405 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 4.21e-04 | 21 | 148 | 3 | GO:0106068 | |
| GeneOntologyCellularComponent | microtubule associated complex | 1.02e-03 | 161 | 148 | 6 | GO:0005875 | |
| GeneOntologyCellularComponent | U2AF complex | 1.02e-03 | 7 | 148 | 2 | GO:0089701 | |
| Domain | Rab_bind | 1.50e-05 | 7 | 143 | 3 | PF16704 | |
| Domain | GCC2_Rab_bind | 1.50e-05 | 7 | 143 | 3 | IPR032023 | |
| Domain | - | 5.07e-05 | 10 | 143 | 3 | 1.10.220.60 | |
| Domain | CTP_synthase_N | 5.82e-05 | 2 | 143 | 2 | IPR017456 | |
| Domain | GATase1_CTP_Synthase | 5.82e-05 | 2 | 143 | 2 | IPR033828 | |
| Domain | CTP_synthase | 5.82e-05 | 2 | 143 | 2 | IPR004468 | |
| Domain | CTP_synth_N | 5.82e-05 | 2 | 143 | 2 | PF06418 | |
| Domain | Grip | 6.93e-05 | 11 | 143 | 3 | SM00755 | |
| Domain | GRIP | 6.93e-05 | 11 | 143 | 3 | PF01465 | |
| Domain | Ran_BP1 | 9.19e-05 | 12 | 143 | 3 | PF00638 | |
| Domain | RANBD1 | 9.19e-05 | 12 | 143 | 3 | PS50196 | |
| Domain | GRIP_dom | 9.19e-05 | 12 | 143 | 3 | IPR000237 | |
| Domain | GRIP | 9.19e-05 | 12 | 143 | 3 | PS50913 | |
| Domain | RanBD | 1.19e-04 | 13 | 143 | 3 | SM00160 | |
| Domain | Ran_bind_dom | 1.19e-04 | 13 | 143 | 3 | IPR000156 | |
| Domain | Znf_C2H2-like | ZNF234 ZNF658 ADNP2 ZNF529 ZNF599 EGR1 ZNF827 MZF1 SF3A3 ZBTB40 ZNF324 ZNF740 PRMT3 DHX34 PRDM16 ZNF367 | 3.99e-04 | 796 | 143 | 16 | IPR015880 |
| Domain | ZnF_C2H2 | ZNF234 ZNF658 ADNP2 ZNF529 ZNF599 EGR1 ZNF827 MZF1 SF3A3 ZBTB40 ZNF324 ZNF740 PRMT3 DHX34 PRDM16 ZNF367 | 4.70e-04 | 808 | 143 | 16 | SM00355 |
| Domain | U2AF_small | 5.73e-04 | 5 | 143 | 2 | IPR009145 | |
| Domain | GATase | 5.73e-04 | 5 | 143 | 2 | PF00117 | |
| Domain | GATASE_TYPE_1 | 8.56e-04 | 6 | 143 | 2 | PS51273 | |
| Domain | GATASE | 8.56e-04 | 6 | 143 | 2 | IPR017926 | |
| Domain | WxxW_domain | 8.56e-04 | 6 | 143 | 2 | IPR025155 | |
| Domain | Mucin2_WxxW | 8.56e-04 | 6 | 143 | 2 | PF13330 | |
| Domain | Ephrin_rec_like | 8.93e-04 | 25 | 143 | 3 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 8.93e-04 | 25 | 143 | 3 | IPR011641 | |
| Domain | P2X_receptor | 1.19e-03 | 7 | 143 | 2 | PF00864 | |
| Domain | P2X_purnocptor | 1.19e-03 | 7 | 143 | 2 | IPR001429 | |
| Domain | - | 1.19e-03 | 7 | 143 | 2 | 2.60.490.10 | |
| Domain | ZnF_UBR1 | 1.19e-03 | 7 | 143 | 2 | SM00396 | |
| Domain | ZF_UBR | 1.19e-03 | 7 | 143 | 2 | PS51157 | |
| Domain | zf-UBR | 1.19e-03 | 7 | 143 | 2 | PF02207 | |
| Domain | Znf_UBR | 1.19e-03 | 7 | 143 | 2 | IPR003126 | |
| Domain | P2X_RECEPTOR | 1.19e-03 | 7 | 143 | 2 | PS01212 | |
| Domain | P2X_extracellular_dom | 1.19e-03 | 7 | 143 | 2 | IPR027309 | |
| Domain | Znf_C2H2 | ZNF234 ZNF658 ADNP2 ZNF529 ZNF599 EGR1 ZNF827 MZF1 SF3A3 ZBTB40 ZNF324 ZNF740 PRMT3 PRDM16 ZNF367 | 1.31e-03 | 805 | 143 | 15 | IPR007087 |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 1.71e-05 | 42 | 109 | 5 | MM15039 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 2.99e-05 | 47 | 109 | 5 | MM14939 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 4.46e-05 | 51 | 109 | 5 | MM15151 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 6.45e-05 | 55 | 109 | 5 | MM14917 | |
| Pathway | REACTOME_AMPLIFICATION_OF_SIGNAL_FROM_THE_KINETOCHORES | 1.23e-04 | 100 | 109 | 6 | MM14561 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 2.49e-04 | 40 | 109 | 4 | MM14945 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 2.75e-04 | 41 | 109 | 4 | MM15200 | |
| Pathway | REACTOME_MITOTIC_SPINDLE_CHECKPOINT | 2.90e-04 | 117 | 109 | 6 | MM15387 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 3.31e-04 | 43 | 109 | 4 | MM14609 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 3.37e-04 | 18 | 109 | 3 | MM1549 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 4.79e-04 | 84 | 109 | 5 | MM14929 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 4.90e-04 | 129 | 109 | 6 | MM14894 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 5.34e-04 | 86 | 109 | 5 | MM15413 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 5.48e-04 | 49 | 109 | 4 | MM14837 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 5.92e-04 | 50 | 109 | 4 | MM14610 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 7.84e-04 | 141 | 109 | 6 | MM15266 | |
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | 3.44e-07 | 153 | 149 | 8 | 26365490 | |
| Pubmed | 4.26e-07 | 15 | 149 | 4 | 14697343 | ||
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | RGPD4 TNPO1 MBNL1 RGPD1 ADD1 TDRD3 RBM19 RGPD3 SF3A3 ISG20L2 CTPS1 | 6.35e-07 | 370 | 149 | 11 | 22922362 |
| Pubmed | RGPD4 RANBP10 ABR ITSN1 RGPD1 ADGRB3 ZMYM2 ARHGEF11 ADD1 TDRD3 P2RX7 UBR5 RGPD3 OTUD4 TNR TBL1X KIF2C | 9.00e-07 | 963 | 149 | 17 | 28671696 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | UBR2 DYNLT2B ABR RHBDF2 KIF1A UBE4B MBNL1 TMEM63C WDR27 ATP10A ITPK1 ADGRG6 PIAS4 ARHGAP6 PTPRJ RDH11 ZNF827 MYH14 ATP11A SLC4A5 TBL1X | 1.64e-06 | 1489 | 149 | 21 | 28611215 |
| Pubmed | 2.66e-06 | 7 | 149 | 3 | 9037092 | ||
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 2.66e-06 | 7 | 149 | 3 | 15710750 | |
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 2.66e-06 | 7 | 149 | 3 | 11353387 | |
| Pubmed | 2.66e-06 | 7 | 149 | 3 | 30944974 | ||
| Pubmed | 2.66e-06 | 7 | 149 | 3 | 38838144 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 2.66e-06 | 7 | 149 | 3 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 2.66e-06 | 7 | 149 | 3 | 17372272 | |
| Pubmed | 2.66e-06 | 7 | 149 | 3 | 38657106 | ||
| Pubmed | 2.66e-06 | 7 | 149 | 3 | 21205196 | ||
| Pubmed | 2.66e-06 | 7 | 149 | 3 | 18949001 | ||
| Pubmed | 2.66e-06 | 7 | 149 | 3 | 25187515 | ||
| Pubmed | 2.66e-06 | 7 | 149 | 3 | 8603673 | ||
| Pubmed | 2.66e-06 | 7 | 149 | 3 | 26632511 | ||
| Pubmed | 2.66e-06 | 7 | 149 | 3 | 24403063 | ||
| Pubmed | 2.66e-06 | 7 | 149 | 3 | 23818861 | ||
| Pubmed | 2.66e-06 | 7 | 149 | 3 | 23536549 | ||
| Pubmed | 2.66e-06 | 7 | 149 | 3 | 12191015 | ||
| Pubmed | 2.66e-06 | 7 | 149 | 3 | 22821000 | ||
| Pubmed | 2.66e-06 | 7 | 149 | 3 | 20682751 | ||
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 4.25e-06 | 8 | 149 | 3 | 21670213 | |
| Pubmed | 4.25e-06 | 8 | 149 | 3 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 4.25e-06 | 8 | 149 | 3 | 21310149 | |
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 4.25e-06 | 8 | 149 | 3 | 22262462 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 4.25e-06 | 8 | 149 | 3 | 28745977 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | RANBP10 ABR RHBDF2 UBE4B EML2 ARHGEF11 LPIN3 PIAS4 MYOF TDRD3 KANSL1 ZNF827 RBM19 MTMR3 PRKDC DHX34 PRDM16 | 5.66e-06 | 1105 | 149 | 17 | 35748872 |
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 6.35e-06 | 9 | 149 | 3 | 18394993 | |
| Pubmed | 6.35e-06 | 9 | 149 | 3 | 28100513 | ||
| Pubmed | 6.35e-06 | 9 | 149 | 3 | 17887960 | ||
| Pubmed | 6.35e-06 | 9 | 149 | 3 | 11553612 | ||
| Pubmed | 6.35e-06 | 9 | 149 | 3 | 10601307 | ||
| Pubmed | 6.35e-06 | 9 | 149 | 3 | 9733766 | ||
| Pubmed | 6.35e-06 | 9 | 149 | 3 | 28877029 | ||
| Pubmed | 8.21e-06 | 234 | 149 | 8 | 36243803 | ||
| Pubmed | 9.05e-06 | 10 | 149 | 3 | 27160050 | ||
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 9.05e-06 | 10 | 149 | 3 | 16332688 | |
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 9.05e-06 | 10 | 149 | 3 | 8857542 | |
| Pubmed | 9.05e-06 | 10 | 149 | 3 | 21859863 | ||
| Pubmed | ZNF234 KIF1A UBE4B KDM4C ZRSR2 TNPO2 ITSN1 GNPTAB ADGRB3 ADNP2 ZMYM2 BHLHE40 CORO2B MYH14 GLS MTMR3 PRKDC KLHL4 | 1.06e-05 | 1285 | 149 | 18 | 35914814 | |
| Pubmed | KDM4C MBNL1 ZMYM2 ZDHHC17 BHLHE40 PIAS4 JARID2 EGR1 UBP1 ZNF324 UHRF1 ZNF740 PRDM16 ZNF367 | 1.08e-05 | 808 | 149 | 14 | 20412781 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | TNPO1 DNHD1 KIF1A API5 GTPBP1 THOC2 JARID2 RDH11 MYH14 RBM19 PRIM1 GLS PES1 SF3A3 UHRF1 PRMT3 PRKDC CTPS1 NUP160 | 1.18e-05 | 1425 | 149 | 19 | 30948266 |
| Pubmed | 1.24e-05 | 11 | 149 | 3 | 17069463 | ||
| Pubmed | 1.24e-05 | 11 | 149 | 3 | 24429156 | ||
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 1.24e-05 | 11 | 149 | 3 | 35771867 | |
| Pubmed | 1.24e-05 | 11 | 149 | 3 | 34110283 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 7513696 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 37146737 | ||
| Pubmed | MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions. | 1.82e-05 | 2 | 149 | 2 | 14988081 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 15563276 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 17621824 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 24317696 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 22391959 | ||
| Pubmed | Mucins MUC5AC and MUC5B Are Variably Packaged in the Same and in Separate Secretory Granules. | 1.82e-05 | 2 | 149 | 2 | 35776514 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 33691379 | ||
| Pubmed | The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1. | 1.82e-05 | 2 | 149 | 2 | 31371437 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 24327612 | ||
| Pubmed | Gel-forming mucins form distinct morphologic structures in airways. | 1.82e-05 | 2 | 149 | 2 | 28607090 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 31030254 | ||
| Pubmed | The idiopathic pulmonary fibrosis honeycomb cyst contains a mucocilary pseudostratified epithelium. | 1.82e-05 | 2 | 149 | 2 | 23527003 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 16540890 | ||
| Pubmed | Abnormalities in MUC5AC and MUC5B Protein in Airway Mucus in Asthma. | 1.82e-05 | 2 | 149 | 2 | 27845589 | |
| Pubmed | DNA-PKcs kinase activity stabilizes the transcription factor Egr1 in activated immune cells. | 1.82e-05 | 2 | 149 | 2 | 34562454 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 27435107 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 26871672 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 38409611 | ||
| Pubmed | In silico cloning of mouse Muc5b gene and upregulation of its expression in mouse asthma model. | 1.82e-05 | 2 | 149 | 2 | 11587997 | |
| Pubmed | Transportin-mediated nuclear import of heterogeneous nuclear RNP proteins. | 1.82e-05 | 2 | 149 | 2 | 9298975 | |
| Pubmed | Pathophysiological relevance of sputum MUC5AC and MUC5B levels in patients with mild asthma. | 1.82e-05 | 2 | 149 | 2 | 34656442 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 34058148 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 28602698 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 14718370 | ||
| Pubmed | Transportin-1 and Transportin-2: protein nuclear import and beyond. | 1.82e-05 | 2 | 149 | 2 | 24780099 | |
| Pubmed | Mucin production during prenatal and postnatal murine lung development. | 1.82e-05 | 2 | 149 | 2 | 21653907 | |
| Pubmed | MUC5B mobilizes and MUC5AC spatially aligns mucociliary transport on human airway epithelium. | 1.82e-05 | 2 | 149 | 2 | 36427316 | |
| Pubmed | Mucin deficiency causes functional and structural changes of the ocular surface. | 1.82e-05 | 2 | 149 | 2 | 23272068 | |
| Pubmed | Younger patients with COME are more likely to have mucoid middle ear fluid containing mucin MUC5B. | 1.82e-05 | 2 | 149 | 2 | 27729120 | |
| Pubmed | Zrsr2 and functional U12-dependent spliceosome are necessary for follicular development. | 1.82e-05 | 2 | 149 | 2 | 35198906 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 36111525 | ||
| Pubmed | Normal murine respiratory tract has its mucus concentrated in clouds based on the Muc5b mucin. | 1.82e-05 | 2 | 149 | 2 | 32348677 | |
| Pubmed | UHRF1 Controls Thymocyte Fate Decisions through the Epigenetic Regulation of EGR1 Expression. | 1.82e-05 | 2 | 149 | 2 | 32358021 | |
| Pubmed | Reassessment of the importance of mucins in determining sputum properties in cystic fibrosis. | 1.82e-05 | 2 | 149 | 2 | 24332705 | |
| Pubmed | Regulation of human cytidine triphosphate synthetase 2 by phosphorylation. | 1.82e-05 | 2 | 149 | 2 | 20739275 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | UBE4B ADNP2 KANSL1 RDH11 UBR5 MYH14 RBM19 GLS PES1 SF3A3 PRMT3 PRR14L PRKDC CTPS1 ALDH9A1 DHX34 NUP160 KIF2C | 2.11e-05 | 1353 | 149 | 18 | 29467282 |
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 2.13e-05 | 38 | 149 | 4 | 12791264 | |
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 2.14e-05 | 13 | 149 | 3 | 31427429 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | UBE4B ITSN1 ZMYM2 THOC2 ADD1 CLASRP TUBGCP6 MYOF KANSL1 ZBTB40 OTUD4 PRKDC CTPS1 | 3.10e-05 | 774 | 149 | 13 | 15302935 |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | DNHD1 MRM2 DYNLT2B ABR CLASRP RCC1L PPP2R5C UBR5 MYH14 PRIM1 ALDH9A1 KIF2C | 3.41e-05 | 670 | 149 | 12 | 22990118 |
| Pubmed | GAK EDC3 ABR API5 GTPBP1 TUBGCP6 UBR5 MYH14 RBM19 PRIM1 PES1 ATP11A PRKDC CTPS1 DHX34 KIF2C | 4.42e-05 | 1168 | 149 | 16 | 19946888 | |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | ZMYM2 GTPBP1 THOC2 ADD1 UBP1 SF3A3 OTUD4 ZNF740 PRKDC CTPS1 NUP160 | 4.59e-05 | 583 | 149 | 11 | 29844126 |
| Pubmed | ITSN1 ADNP2 ZMYM2 ZDHHC17 ARHGEF11 BHLHE40 FBXO30 KANSL1 EGR1 PRKDC | 5.01e-05 | 486 | 149 | 10 | 20936779 | |
| Pubmed | 5.45e-05 | 3 | 149 | 2 | 16179339 | ||
| Pubmed | Isolation and mapping of human homologues of an imprinted mouse gene U2af1-rs1. | 5.45e-05 | 3 | 149 | 2 | 8586425 | |
| Pubmed | 5.45e-05 | 3 | 149 | 2 | 29286856 | ||
| Pubmed | 5.45e-05 | 3 | 149 | 2 | 36675209 | ||
| Pubmed | 5.45e-05 | 3 | 149 | 2 | 29802623 | ||
| Pubmed | Resistin upregulates MUC5AC/B mucin gene expression in human airway epithelial cells. | 5.45e-05 | 3 | 149 | 2 | 29604272 | |
| Interaction | TIGD3 interactions | 1.80e-06 | 13 | 146 | 4 | int:TIGD3 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF234 ZNF658 ADNP2 ZNF529 ZNF599 EGR1 ZNF827 MZF1 ZBTB40 ZNF324 ZNF740 PRDM16 ZNF367 | 4.19e-04 | 718 | 110 | 13 | 28 |
| GeneFamily | Purinergic receptors P2X | 7.55e-04 | 7 | 110 | 2 | 214 | |
| GeneFamily | Ubiquitin protein ligase E3 component n-recognins | 7.55e-04 | 7 | 110 | 2 | 785 | |
| GeneFamily | Olfactory receptors, family 14 | 7.55e-04 | 7 | 110 | 2 | 163 | |
| GeneFamily | Zinc fingers CCCH-type | 1.24e-03 | 35 | 110 | 3 | 73 | |
| GeneFamily | Tudor domain containing | 1.46e-03 | 37 | 110 | 3 | 780 | |
| GeneFamily | Myotubularins|Phosphoinositide phosphatases | 3.66e-03 | 15 | 110 | 2 | 903 | |
| GeneFamily | ATPase phospholipid transporting | 3.66e-03 | 15 | 110 | 2 | 1210 | |
| GeneFamily | Armadillo repeat containing|Importins | 5.27e-03 | 18 | 110 | 2 | 596 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 5.35e-03 | 115 | 110 | 4 | 769 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | UBR2 SEMA3C KDM4C ITSN1 MBNL1 ZMYM2 ZDHHC17 THOC2 BHLHE40 ADGRG6 JARID2 MYOF TDRD3 PPP2R5C UBR5 MTMR3 OTUD4 PRMT3 NUP160 TBL1X | 6.46e-08 | 856 | 146 | 20 | M4500 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | UBR2 SEMA3C ITSN1 MBNL1 ZMYM2 ZDHHC17 BHLHE40 ADGRG6 JARID2 PPP2R5C UBR5 PRMT3 TBL1X | 2.23e-06 | 466 | 146 | 13 | M13522 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | TNPO1 UBR2 KIF1A UBE4B ANKRD10 MBNL1 ZMYM2 API5 THOC2 ATP10A ADD1 TDRD3 PPP2R5C RDH11 UBR5 EGR1 GLS KCTD20 OTUD4 PRKDC NUP160 | 3.97e-06 | 1215 | 146 | 21 | M41122 |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.15e-06 | 186 | 149 | 7 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.38e-06 | 188 | 149 | 7 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-05 | 160 | 149 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-05 | 160 | 149 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | LA-16._Neuronal|World / Chamber and Cluster_Paper | 2.19e-05 | 168 | 149 | 6 | 2fd1fd2a16ac1c5eb028f93cc3a2477c7747693e | |
| ToppCell | LA-16._Neuronal|LA / Chamber and Cluster_Paper | 2.19e-05 | 168 | 149 | 6 | c55bbfbde8bb954f1cb9af82007bdd1f8070fee3 | |
| ToppCell | COVID-19_Mild-PLT_2|World / Disease Group and Platelet Clusters | 2.26e-05 | 169 | 149 | 6 | 6abfdc8b437f19c03b408bedc245059d28c6ba6a | |
| ToppCell | COVID-19_Mild-PLT_2|COVID-19_Mild / Disease Group and Platelet Clusters | 2.58e-05 | 173 | 149 | 6 | d11705e56b6b21eec963ea224717f27680c781ed | |
| ToppCell | COVID-19-Heart-Neuronal|Heart / Disease (COVID-19 only), tissue and cell type | 2.58e-05 | 173 | 149 | 6 | 6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.84e-05 | 176 | 149 | 6 | 852d3da0907fe87c0ef23d75a63ce07619cf0c54 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.84e-05 | 176 | 149 | 6 | d2df1e435996c51213e88270af9f928e9e09a6f5 | |
| ToppCell | facs-Brain_Myeloid-Striatum-24m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-05 | 177 | 149 | 6 | f6b9d91d46830d0d207b0abd4ee5a4942fd99774 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 3.54e-05 | 183 | 149 | 6 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-Tuft-related|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.54e-05 | 183 | 149 | 6 | 263937906ddabc798bbe60f0da28ba859a5c72e2 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.76e-05 | 185 | 149 | 6 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.99e-05 | 187 | 149 | 6 | a9316e2818217ec5feae9cf8816f7249803caee6 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.23e-05 | 189 | 149 | 6 | 8c8ca3b30d9be6c854615459a7bfba82b427c8bc | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.23e-05 | 189 | 149 | 6 | 5d902a4660a27548764bf04c6de152b565da835c | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.23e-05 | 189 | 149 | 6 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Neuronal-Glial_mature|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.62e-05 | 192 | 149 | 6 | ac507fd7cf3b3e521a15ef03bb4e81eb23807985 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Neuronal|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.62e-05 | 192 | 149 | 6 | 24f40dadec04f4f99c31000fa9f09d07148fa190 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Neuronal-Glial_mature-Adult_Glia|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.62e-05 | 192 | 149 | 6 | 71e04e197825856c6d4278fc76c58ab17ffa2387 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.76e-05 | 193 | 149 | 6 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.76e-05 | 193 | 149 | 6 | f25bdd10ef531b8d8441ea84573078b4b1b0f105 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.90e-05 | 194 | 149 | 6 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Neuronal-Glial_mature-Adult_Glia|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.90e-05 | 194 | 149 | 6 | d429bb5e422a07bd92f0dc48cd51528e8b7d9a72 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.90e-05 | 194 | 149 | 6 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Neuronal|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.90e-05 | 194 | 149 | 6 | bffdf6db0bf3fb338e7bb0789ae7dcde1fce0094 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Neuronal-Glial_mature|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.90e-05 | 194 | 149 | 6 | 408dfc7060095972a54ae37ae8105521df6fbbee | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.04e-05 | 195 | 149 | 6 | cec7df321f372d05c94f97d6bb18891a5cc3dec3 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.18e-05 | 196 | 149 | 6 | df366d76ea55f49e349d622effa57c1535df8400 | |
| ToppCell | (02)_MMP9/10+-(1)_GFP|(02)_MMP9/10+ / shred by cell type by condition | 5.64e-05 | 199 | 149 | 6 | 448ba982be804007f991d469eca9d885b21ae499 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 5.64e-05 | 199 | 149 | 6 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 5.80e-05 | 200 | 149 | 6 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| Drug | Lorglumide sodium salt [97964-56-2]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 6.07e-07 | 196 | 147 | 10 | 5619_DN | |
| Drug | Trifluridine [70-00-8]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 4.52e-06 | 192 | 147 | 9 | 7176_DN | |
| Drug | Benfotiamine [22457-89-2]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 5.35e-06 | 196 | 147 | 9 | 3837_UP | |
| Drug | Catechin-(+,-) hydrate [7295-85-4]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 5.57e-06 | 197 | 147 | 9 | 3351_UP | |
| Drug | Josamycin [16846-24-5]; Down 200; 4.8uM; MCF7; HT_HG-U133A | CACNA1D RANBP10 KIF1A PIAS4 MYOF KCTD20 ZNF324 SECISBP2 PRR14L | 5.81e-06 | 198 | 147 | 9 | 1534_DN |
| Drug | Cinnarizine [298-57-7]; Down 200; 10.8uM; PC3; HT_HG-U133A | 6.05e-06 | 199 | 147 | 9 | 5817_DN | |
| Drug | Moxisylyte hydrochoride [964-52-3]; Up 200; 12.6uM; HL60; HT_HG-U133A | 6.30e-06 | 200 | 147 | 9 | 1846_UP | |
| Drug | Mometasone furoate [83919-23-7]; Down 200; 7.6uM; PC3; HT_HG-U133A | 3.12e-05 | 188 | 147 | 8 | 5116_DN | |
| Drug | Pentamidine isethionate [140-64-7]; Down 200; 6.8uM; HL60; HT_HG-U133A | 4.20e-05 | 196 | 147 | 8 | 2473_DN | |
| Drug | Tranylcypromine hydrochloride [1986-47-6]; Up 200; 23.6uM; PC3; HT_HG-U133A | 4.20e-05 | 196 | 147 | 8 | 2101_UP | |
| Drug | Fipexide hydrochloride [34161-23-4]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 4.35e-05 | 197 | 147 | 8 | 3176_DN | |
| Drug | Bromocryptine mesylate [22260-51-1]; Down 200; 5.4uM; PC3; HT_HG-U133A | 4.35e-05 | 197 | 147 | 8 | 4604_DN | |
| Drug | LY 294002; Down 200; 0.1uM; MCF7; HT_HG-U133A | 4.35e-05 | 197 | 147 | 8 | 6935_DN | |
| Drug | Dextromethorphan hydrobromide monohydrate [6700-34-1]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 4.35e-05 | 197 | 147 | 8 | 2636_DN | |
| Drug | Hydroflumethiazide [135-09-1]; Up 200; 12uM; HL60; HT_HG-U133A | 4.51e-05 | 198 | 147 | 8 | 1851_UP | |
| Drug | Isradipine [75695-93-1]; Up 200; 10.8uM; PC3; HT_HG-U133A | 4.51e-05 | 198 | 147 | 8 | 6347_UP | |
| Drug | Butirosin disulfate salt [51022-98-1]; Down 200; 5.4uM; MCF7; HT_HG-U133A | 4.51e-05 | 198 | 147 | 8 | 6080_DN | |
| Drug | Ozagrel hydrochloride [78712-43-3]; Up 200; 15.2uM; PC3; HT_HG-U133A | 4.67e-05 | 199 | 147 | 8 | 7281_UP | |
| Drug | Gliclazide [21187-98-4]; Down 200; 12.4uM; HL60; HG-U133A | 4.84e-05 | 200 | 147 | 8 | 1720_DN | |
| Disease | intellectual developmental disorder with hypotonia, impaired speech, and dysmorphic facies (implicated_via_orthology) | 2.37e-05 | 2 | 144 | 2 | DOID:0081262 (implicated_via_orthology) | |
| Disease | chronic obstructive pulmonary disease, interleukin-8 measurement | 1.41e-04 | 4 | 144 | 2 | EFO_0000341, EFO_0004811 | |
| Disease | idiopathic pulmonary fibrosis | 1.76e-04 | 57 | 144 | 4 | EFO_0000768 | |
| Disease | platelet crit | TNPO1 DNAH3 SLFN14 ARHGEF11 ITPK1 LPIN3 KANSL1 PRIM1 OTUD4 ISG20L2 CTPS1 PRDM16 NUP160 ZNF367 | 2.44e-04 | 952 | 144 | 14 | EFO_0007985 |
| Disease | severe acute respiratory syndrome, COVID-19 | 3.64e-04 | 447 | 144 | 9 | EFO_0000694, MONDO_0100096 | |
| Disease | red blood cell density measurement | SEMA3C ITSN1 MBNL1 ARHGEF11 TG KANSL1 UBR5 ZNF827 DPEP2 ZBTB40 OTUD4 ATP11A MYO15A | 3.92e-04 | 880 | 144 | 13 | EFO_0007978 |
| Disease | biliary tract benign neoplasm (is_marker_for) | 4.89e-04 | 7 | 144 | 2 | DOID:0050625 (is_marker_for) | |
| Disease | glucose measurement | 5.79e-04 | 380 | 144 | 8 | EFO_0004468 | |
| Disease | COVID-19 symptoms measurement | 6.64e-04 | 35 | 144 | 3 | EFO_0600019 | |
| Disease | long QT syndrome (implicated_via_orthology) | 1.04e-03 | 10 | 144 | 2 | DOID:2843 (implicated_via_orthology) | |
| Disease | aortic valve stenosis (is_marker_for) | 1.26e-03 | 11 | 144 | 2 | DOID:1712 (is_marker_for) | |
| Disease | pulmonary fibrosis | 1.26e-03 | 11 | 144 | 2 | EFO_0009448 | |
| Disease | body surface area | 1.27e-03 | 643 | 144 | 10 | EFO_0022196 | |
| Disease | chronic obstructive pulmonary disease (is_marker_for) | 1.33e-03 | 97 | 144 | 4 | DOID:3083 (is_marker_for) | |
| Disease | interleukin 17 measurement | 1.39e-03 | 45 | 144 | 3 | EFO_0008174 | |
| Disease | alkaline phosphatase measurement | BHLHE40 KIRREL3 PPP2R5C KANSL1 PTPRJ P2RX7 ZNF827 DPEP2 UBP1 ZBTB40 PRR14L NUP160 MAP4K2 | 1.45e-03 | 1015 | 144 | 13 | EFO_0004533 |
| Disease | survival time, breast carcinoma | 1.78e-03 | 13 | 144 | 2 | EFO_0000305, EFO_0000714 | |
| Disease | advanced glycosylation end product-specific receptor, soluble measurement | 1.78e-03 | 13 | 144 | 2 | EFO_0020131 | |
| Disease | mean reticulocyte volume | TNPO1 KDM4C ITSN1 GTPBP1 KANSL1 PTPRJ DPEP2 PRIM1 ZBTB40 OTUD4 PRDM16 | 1.93e-03 | 799 | 144 | 11 | EFO_0010701 |
| Disease | treatment-resistant hypertension | 2.04e-03 | 109 | 144 | 4 | EFO_1002006 | |
| Disease | Hamman-Rich syndrome | 2.07e-03 | 14 | 144 | 2 | C0085786 | |
| Disease | coronary artery disease | SEMA3C KCNH7 KIF1A SVEP1 ITPK1 FBN2 PTPRJ ZNF827 GLS SF3A3 UHRF1 PRDM16 NUP160 TBL1X | 2.17e-03 | 1194 | 144 | 14 | EFO_0001645 |
| Disease | Chronic Lymphocytic Leukemia | 2.48e-03 | 55 | 144 | 3 | C0023434 | |
| Disease | lean body mass | 2.67e-03 | 379 | 144 | 7 | EFO_0004995 | |
| Disease | nervousness | 2.71e-03 | 16 | 144 | 2 | NCIT_C74532 | |
| Disease | alpha-L-iduronidase measurement | 3.07e-03 | 17 | 144 | 2 | EFO_0020139 | |
| Disease | asthma (is_marker_for) | 3.44e-03 | 126 | 144 | 4 | DOID:2841 (is_marker_for) | |
| Disease | Usual Interstitial Pneumonia | 3.83e-03 | 19 | 144 | 2 | C4721509 | |
| Disease | Hamman-Rich Disease | 3.83e-03 | 19 | 144 | 2 | C4721508 | |
| Disease | hydrocephalus (implicated_via_orthology) | 3.83e-03 | 19 | 144 | 2 | DOID:10908 (implicated_via_orthology) | |
| Disease | response to vaccine, cytokine measurement | 3.95e-03 | 131 | 144 | 4 | EFO_0004645, EFO_0004873 | |
| Disease | Familial Idiopathic Pulmonary Fibrosis | 4.24e-03 | 20 | 144 | 2 | C4721952 | |
| Disease | interstitial lung disease | 4.34e-03 | 67 | 144 | 3 | EFO_0004244 | |
| Disease | Idiopathic Pulmonary Fibrosis | 4.67e-03 | 21 | 144 | 2 | C1800706 | |
| Disease | Profound Mental Retardation | 4.87e-03 | 139 | 144 | 4 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 4.87e-03 | 139 | 144 | 4 | C0025363 | |
| Disease | Mental deficiency | 4.87e-03 | 139 | 144 | 4 | C0917816 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CSTLVTAPGQHLKFQ | 286 | Q9UK28 | |
| GPALHVFNVKCEAQR | 66 | Q6ZRU5 | |
| TGSCFKLRTVHNIPV | 476 | Q12979 | |
| SVKAVQHGKPIFICQ | 111 | O14734 | |
| HNPGACVALVSVRVF | 186 | P21709 | |
| GQFLCQHPDVAKVSF | 216 | P49189 | |
| KQLVCPVTRDHLGFQ | 441 | P22792 | |
| VFPNHISVGTNRKRC | 201 | Q9NXR5 | |
| LVLNKVSPSQFGCHV | 156 | O60242 | |
| LRQCFHGQVLVKTGP | 1206 | Q86SQ4 | |
| GKNCVPVIQRTFAHS | 216 | O14503 | |
| GQRHKVKSQGACVTP | 651 | O00178 | |
| TKGPVLHDQDTRCAF | 81 | Q96L96 | |
| RCVIIQKDQHGFGFT | 46 | O15085 | |
| LAKCVSSPHFQVAER | 331 | Q13362 | |
| CTRQAVPLFSKNVHS | 241 | Q9BZZ5 | |
| VHAVSFRSCPTGEKN | 1391 | Q96M86 | |
| LQPCSSVDARGRHQK | 776 | O60312 | |
| CVFASQPKVVGRHFR | 111 | Q6IQ32 | |
| TANPCSRKKVHFGSI | 16 | Q8N9B4 | |
| AQKQCSILHGPTFAA | 1081 | Q9HC84 | |
| STQVNVPRCLHFSGV | 321 | Q96I51 | |
| VPRCLHFSGVGKVRQ | 326 | Q96I51 | |
| KVQGTVHCFPISARL | 236 | Q6VN20 | |
| TTCHTVKLRGAPFNV | 291 | Q9Y4C8 | |
| SNPCVQRKSSHVGDR | 486 | Q01804 | |
| QRHSTGDTKVPFCLQ | 271 | O94925 | |
| KVFNGCPLRIHAAVT | 476 | Q12851 | |
| TRHEGSFQVPVLCAV | 31 | Q07108 | |
| VKQVDGSFRCSPFHV | 36 | Q9BQK8 | |
| CVAGFTNITFHPQNK | 931 | Q12913 | |
| TFPFICKTRVAHGTN | 151 | Q13572 | |
| SNNRIQVFKPCGAFH | 626 | Q2Q1W2 | |
| HALVTTECPQKGRNF | 321 | Q8IV33 | |
| QRLTFPAVSVKVNGH | 786 | Q3T906 | |
| PHCRTRIGFQSLIQK | 411 | Q9C0I1 | |
| IFVVTNRGQHVCPLS | 3256 | Q9UKN7 | |
| SCFQSGNKRNHEPFI | 81 | Q7Z5Y7 | |
| KNGSTFICNTHIIPV | 101 | Q9NS40 | |
| HCLGFAPRNSQKVTR | 206 | Q9P1W3 | |
| TRHIRIHTGQKPFQC | 356 | P18146 | |
| SFVRCIVPNHEKRAG | 691 | Q7Z406 | |
| NFSIPLCGKRVIHQF | 161 | Q9UGF5 | |
| RQSKAFSNCVPHLIV | 231 | Q8NGZ2 | |
| RFCSQLVKRQHPGVK | 141 | Q8N8M0 | |
| PKGHVSSLARCSIVN | 191 | Q9H9L3 | |
| KVHRNSTIRPGCDVN | 616 | Q7Z3B3 | |
| VVNITCFRHKVNPNV | 856 | Q9H3R0 | |
| CQPAQAFVVKRGVHV | 371 | Q96RT7 | |
| PHCNSASTRIFGKQT | 111 | Q05C16 | |
| AQKQCSILHGPTFAA | 1091 | P98088 | |
| SPCKDINTFIHGNKR | 61 | P03950 | |
| FHNGVKCLVPEVTFR | 41 | Q96F86 | |
| NPAVHFAQVVKECRA | 601 | Q96FC9 | |
| HQFCSRSGQPTKKNV | 166 | Q86X67 | |
| IKQLHPSNCLGIRSF | 276 | Q9C0H6 | |
| SPGSQAQKVIICHRG | 246 | Q7RTS3 | |
| SRACSTPHVQVAGKA | 816 | O43182 | |
| CFPRLDINVSKGINH | 301 | P49642 | |
| RNILPGLNITCTFHK | 206 | Q99572 | |
| VCTLIHRKAVPGNSA | 536 | A6NKT7 | |
| KLSGHPNIVQFCSAA | 91 | O14976 | |
| IGNKNAVFHIKTCRP | 226 | Q4G0P3 | |
| NREHCFDGIPITKNV | 26 | Q9UQ03 | |
| NGKFTLVVPHQHRNC | 191 | P24387 | |
| EFGRLHCKFVVQTSP | 1896 | Q8TD57 | |
| KNCHNRVVFSTGPQS | 461 | O60678 | |
| FNSVTNCLGPRKFLH | 1451 | Q15811 | |
| FAHPSKSCQVENGRV | 36 | Q9NR56 | |
| APVIFSHSAARGVCN | 276 | Q9H4A9 | |
| VVTFHCSAKANPAVT | 266 | Q8IZU9 | |
| HPSRAQFVTCGQDKL | 386 | O95834 | |
| HAGFQRTPTKQACID | 561 | P35556 | |
| QRRFCPSIQGAKIIH | 566 | Q8TB52 | |
| TQAKQGAVLHPTCVF | 831 | Q14147 | |
| CIRALGQNKAHTPFR | 526 | Q99661 | |
| FFILSKTNPIRVGCH | 866 | Q01668 | |
| QQRFRPSVVKDCIHA | 36 | Q8WW35 | |
| LKTPNTFAVCTEHRG | 1636 | Q12756 | |
| CRPGEHVTSRFKNEV | 151 | Q13615 | |
| VKTGQCVVFNGTHRT | 156 | O15547 | |
| GDPVSNISQTHFKCR | 1366 | Q5THK1 | |
| VIAKVSGNTHSIFCP | 1111 | A6NGG8 | |
| AVCTLIHRKAVPGNS | 526 | P0DJD0 | |
| KVHRTVQQSGQFVVC | 996 | Q92833 | |
| LNSCFVKVPRSEGHE | 86 | A0A1W2PRP0 | |
| GICKVHPALNVSTRT | 336 | P53609 | |
| SAVLCHPKQGQKSVR | 1236 | Q8NET4 | |
| FIKTPQQGAQTSLHC | 256 | Q8TC12 | |
| VCTLIHRKAVPGNSA | 536 | Q7Z3J3 | |
| GQRSRDVPQKCTLHA | 146 | Q6ZRF8 | |
| AQFPRKTITSGIHCA | 721 | P0C7P3 | |
| FVPFGQKCVSHVQVD | 91 | Q9H7E2 | |
| KDPTHGCGNFVRVIQ | 106 | Q99985 | |
| KHVTATVACQRLGPS | 356 | Q8N3T6 | |
| VVQCSNFRDKHVPLT | 581 | Q9NTG1 | |
| QARKIGNITHSIPAC | 2846 | P25391 | |
| NCVKVFTDPSNLQRH | 341 | Q9HAZ2 | |
| KRENFCNIHVSLVPQ | 171 | P17812 | |
| GFQTVKHRNENTCPL | 121 | Q96T21 | |
| HVKNFRPQCIVLTGG | 676 | Q13621 | |
| KSVGSPVFVCQANRH | 2236 | Q4LDE5 | |
| HAPKRGQFCIFQLVS | 361 | Q12769 | |
| DSGTCSPLRHSFQKQ | 426 | P35611 | |
| DPAQFLQVHGRACKV | 36 | Q8N2M8 | |
| NQCPVHFIQHGKLVR | 126 | P98196 | |
| SIACRVHAGPVRQQS | 31 | P49406 | |
| CDRPVKTFQGHTNEV | 401 | O60907 | |
| QQVTLRCSPISGHKS | 36 | A0A597 | |
| KRENFCNIHVSLVPQ | 171 | Q9NRF8 | |
| QSPSAGVHTFCDRQK | 226 | Q8N5D0 | |
| FLLPRKCHSSGEVQN | 306 | Q8N5D0 | |
| ECGKAFTQPANFVRH | 511 | Q96NL3 | |
| CQVAPLTHVFQRQKS | 156 | Q9BYV6 | |
| PVAGACHSVKSLQRQ | 111 | O75467 | |
| CHSVKSLQRQRGASP | 116 | O75467 | |
| CARFVELVHQQKTPN | 996 | Q8NI27 | |
| HQEKCSFLLRPTQGT | 56 | H3BPM6 | |
| TFPRTGKCHVQTIQL | 146 | O00541 | |
| ISHQQCPGKTSTSFR | 156 | Q6ZMT1 | |
| FGKTHPVCNLVASLR | 556 | O95155 | |
| PKIRSHAIACVNQFI | 186 | O14787 | |
| QVTFTHRINFPKKAC | 111 | Q92752 | |
| QCGETFNRPSKVIQH | 211 | A6NDX5 | |
| SDPQNGIHCIARKRS | 1116 | Q9BY07 | |
| KTVVVRCGQRAHPSN | 186 | A1L157 | |
| PKIRSHAVACVNQFI | 196 | Q92973 | |
| KLVCVSFQRQGFHTV | 6 | Q9UI43 | |
| NIAVKVNHSYCSVPG | 211 | Q8N2W9 | |
| KGPVLRNCISTVVHQ | 471 | P78527 | |
| KCFIQPSQFQAHRRI | 351 | Q14588 | |
| SIESPFNHGCVRNII | 581 | Q8IUH5 | |
| NVCGKPFAHNSTLRV | 941 | Q5TYW1 | |
| HETVNFSGVKRPFCS | 691 | Q9UBW7 | |
| VCGKVFGRQQTLSRH | 821 | Q17R98 | |
| PAKRTSAFIQVHCIS | 176 | Q9NZI7 | |
| VFRPITTVCQHNVCK | 731 | Q96T88 | |
| RCLGIPNTAHFANVT | 436 | Q12874 | |
| FKVSCNLEPHLRGNV | 261 | Q15695 | |
| IGRGNFKPKQHTVIC | 41 | Q8WTV1 | |
| NSFSVVGHLTCQPKI | 541 | Q6P280 | |
| SRPVHQICQNKGSSF | 701 | A2RRH5 | |
| FQTSHICKGSALQPQ | 36 | Q6AWC8 | |
| QRLHTGEKPFVCSEN | 216 | Q7RTV3 | |
| GSFQVKIPKNFVCEH | 91 | Q8NDX6 | |
| QANKPSHLCGRVFKV | 91 | Q8IWV8 | |
| QKRTSGAVCHQDPRT | 541 | Q6PJF5 | |
| RCQVKVRSHGQDSPA | 1661 | P01266 | |
| FKVSCNLEPHLRGNV | 256 | Q15696 | |
| AVVSQHPSRVICKSG | 16 | A0A075B6N2 | |
| ATIKQCVVGPNHAAF | 46 | O95071 | |
| QVHVKCQHSGSQPFR | 1091 | Q9NUA8 | |
| NVCGKPFAHNSTLRV | 701 | Q4V348 | |
| LSGNNIRPVVKVHVC | 211 | Q9NZM1 | |
| CGKAFRQRPTLTQHL | 686 | P28698 |